Pacanalotamab Biosimilar - Anti-TNFRSF17;CD3E mAb - Research Grade
Source
CAS 2251756-52-0
Species
Humanized
Expression system
XtenCHO
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery lead time in business days
3-5 days if in stock; 3-5 weeks if production needed
Delivery Time
3-5 days if in stock; 3 week if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Pacanalotamab,AMG420,BISPECIFIC T-CELL ENGAGER ANTIBODY WITH A SINGLE CHAIN FC MOIETY THAT BINDS TO B CELL MATURATION, ANTIGEN SURFACE RECEPTOR AND CD3, AMG-420, BI-836909,TNFRSF17;CD3E,anti-TNFRSF17;CD3E
Reference
PX-TA1698
Note
For research use only. Not suitable for human use.
Hellberg, Ella, Development of immunoassays that can assess therapeutic bispecific antibodies on the Gyrolab platform, 2023, Independent thesis Advanced level,urn:nbn:se:uu:diva-507186
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Pacanalotamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.